What is the recommended treatment for uncomplicated gonorrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Uncomplicated Gonorrhea

The recommended first-line treatment for uncomplicated gonorrhea is ceftriaxone 500 mg intramuscular (IM) as a single dose. 1, 2

Current Treatment Recommendations

First-Line Regimen

  • Ceftriaxone 500 mg IM as a single dose 1, 2
    • For patients weighing ≥150 kg (331 lbs), increase dose to 1 g IM 1
    • Administer in the gluteal muscle (preferred site) or deltoid muscle 1, 3
    • If chlamydial infection has not been excluded, add doxycycline 100 mg orally twice daily for 7 days 1, 2

Alternative Regimens (for cephalosporin allergy or unavailability)

  1. Spectinomycin 2 g IM as a single dose 4, 1

    • Note: Less effective for pharyngeal infections (only 52% effective) 1
  2. Gentamicin 240 mg IM plus azithromycin 2 g orally as a single dose 1, 5

    • Clinical trial showed 100% efficacy for urogenital infections 5
    • Gastrointestinal side effects are common 5

Important Clinical Considerations

Site-Specific Treatment

  • Pharyngeal infections:
    • Require higher doses of antibiotics due to difficulty in eradication 4, 1
    • Test-of-cure recommended 7-14 days after treatment, especially if using alternative regimens 1

Special Populations

  • Pregnant patients:
    • Ceftriaxone is safe in pregnancy 1
    • Avoid quinolones and tetracyclines 1
    • For cephalosporin allergy: spectinomycin 2 g IM 1

Follow-up

  • Patients should abstain from sexual activity until:
    • Therapy is completed
    • Both patient and partners no longer have symptoms 1
  • Retest approximately 3 months after treatment due to high reinfection rates 1

Treatment Pitfalls to Avoid

  1. Do not use quinolones (ciprofloxacin, ofloxacin):

    • No longer recommended due to widespread resistance 4, 1, 2
  2. Azithromycin monotherapy is not recommended:

    • Increasing resistance has led to removal from recommended dual therapy 1
    • Single 2 g dose causes significant gastrointestinal distress 4, 6
  3. When administering ceftriaxone:

    • Do not use diluents containing calcium (e.g., Ringer's solution) 3
    • Administer over 30 minutes if given intravenously 3
  4. Partner management:

    • All sex partners from previous 60 days should be evaluated and treated 1
    • Failure to treat partners is a common cause of reinfection

Evolution of Treatment Guidelines

Treatment recommendations have evolved due to antimicrobial resistance patterns:

  • Earlier guidelines (2006) included options like cefixime 400 mg orally 4, 7
  • Current guidelines (2020-2025) recommend higher doses of ceftriaxone (500 mg vs. previous 250 mg) due to concerns about resistance 1, 2

The shift to ceftriaxone 500 mg IM as the sole first-line agent reflects the urgent need to preserve antibiotic effectiveness against gonorrhea in the face of increasing antimicrobial resistance 2.

References

Guideline

Administration of Intramuscular STI Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020.

MMWR. Morbidity and mortality weekly report, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.